Erudio Healtherudio.com
Drug
Methylprednisolone trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying methylprednisolone: VA STARPORT. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 4 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| VA STARPORT NCT04787744 · VA Office of Research and Development | oligometastatic prostate cancer | Phase 2/Phase 3 | 119 | 25 | Focused | Oct 29, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| ZUMA-1 NCT02348216 · Kite, A Gilead Company DeepView → | refractory large B-cell lymphoma | Phase 1/Phase 2 | Deep | View | |||
| IRAKLIA NCT05405166 · Sanofi DeepView → | relapsed/refractory multiple myeloma | Phase 3 | Deep | View | |||
| AHOD1331 NCT02166463 · National Cancer Institute (NCI) StandardView → | newly diagnosed high-risk pediatric classical Hodgkin lymphoma | Phase 3 | Standard | View | |||
| IZALCO NCT05704049 · Sanofi StandardView → | relapsed/refractory multiple myeloma | Phase 2 | Standard | View | |||